Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Brussels Capital Region, Belgium Clinical Trials

A listing of Brussels Capital Region, Belgium clinical trials actively recruiting patients volunteers.

RESULTS

Found (4) clinical trials

alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells

This open-label Phase I study aims at assessing the safety, cell kinetics and clinical activity of the CYAD-101 treatment administered 3 times with a 2-week interval between each administration in metastatic CRC, concurrently with a standard chemotherapy treatment. The standard chemotherapy treatment consists of 6 consecutive cycles of FOLFOX administered ...

Phase

0.0 miles

Learn More »

Initiation of Ovarian Stimulation With Recombinant-human FSH (Bemfola ) in the Late Follicular Phase

Objective: To determine whether late follicular stimulation using recombinant-human FSH has comparable outcomes to treatment using recombinant-human FSH in early follicular phase in a flexible GnRH (Gonadotropin-releasing hormone) antagonist protocol, in oocyte donor patients. Design: Open label, phase 3 pilot randomized trial using a two-arm design with 1:1 allocation ratio ...

Phase

1.9 miles

Learn More »

Myo-inositol as Pretreatment in Hyperandrogenic PCOS Patients

A randomized controlled trial to evaluate whether pretreatment with myo-inositol can lower testosterone levels and improve clinical outcomes in hyperandrogenic PCOS patients undergoing ART

Phase

1.9 miles

Learn More »

Study to Evaluate Safety and Antiviral Activity of Doses of JNJ-53718678 in Children (>=28 Days to <=3 Years) With Respiratory Syncytial Virus Infection

JNJ-53718678 is an investigational respiratory syncytial virus (RSV) specific fusion inhibitor and is under development for the treatment of RSV infection, which results in an upper and/or lower respiratory tract illness. The primary hypothesis of this study is that JNJ-53718678 has antiviral activity against RSV (that is, results in a ...

Phase

2.12 miles

Learn More »